Effect of bortezomib and cetuximab in EGF-stimulated HNSCC.
Wagenblast J, Baghi M, Arnoldner C, Bisdas S, Gstöttner W, Ackermann H, May A, Knecht R, Hambek M.
Wagenblast J, et al. Among authors: arnoldner c.
Anticancer Res. 2008 Jul-Aug;28(4B):2239-43.
Anticancer Res. 2008.
PMID: 18751401
Free article.